NCI researchers have published a review in CA: A Cancer Journal for Clinicans that outlines what is known and unknown about multi-cancer detection assay technologies.  “MCD tests can potentially be used to improve early cancer detection, including cancers that currently lack effective… Learn more
POSTED: 3/25/2024
AACR Annual Meeting 2024
Consider attending these AACR sessions to learn about the latest DCP funding opportunities in cancer prevention, interception, and symptom science; research resources and workforce activities; multi-cancer detection tests… Learn more
POSTED: 3/12/2024
Consider attending these DCP PREVENT-funded project presentations at AACR to learn about preclinical development of innovative interventions and biomarkers for cancer prevention and interception.
POSTED: 3/12/2024
A middle-aged man sitting on a hospital bed having his blood drawn by a medical technologist.
The National Institutes of Health (NIH) has launched a clinical trials network to evaluate emerging technologies for cancer screening. The Cancer Screening Research Network (CSRN) will support the Biden-Harris administration… Learn more
POSTED: 2/21/2024
Worta McCaskill-Stevens, M.D.
The 2024 AACR Distinguished Public Service Award will be given posthumously to NCI cancer researcher Worta McCaskill-Stevens, M.D., at the AACR Annual Meeting 2024, to be held from April 5-10 at the San Diego Convention… Learn more
POSTED: 2/19/2024
Whole cranberries in a bowl and placed within a drink in a glass.
Findings from two studies aimed at learning more about preventing the type of esophageal cancer with the fastest growing incidence rate have emerged recently from the Barrett’s Esophagus Translational Research Network (… Learn more
POSTED: 1/30/2024
AUTHOR: Susan Jenks
Screen capture of the January 2024 issue of CP-CTNet Newseltter
Staff Highlight, DMACC Updates, Research Funding Opportunities, Active and DCP-Approved Studies, Upcoming Events
POSTED: 1/30/2024
A female health provider positions a patient undergoing a mammogram.
Cancer screening tests can help doctors find several forms of the disease at an early stage. The US Preventive Services Task Force (USPSTF) recommends routine screening for breast, cervical, colorectal, and lung cancer. But… Learn more
POSTED: 1/26/2024
'Last Mile' Sites
On January 25, 2024, the National Cancer Institute (NCI), part of the National Institutes of Health, with public and private partners, is launching a new clinical trial network to gather data on a “self-collection” method of… Learn more
POSTED: 1/25/2024
A woman in scrubs, sitting at a desk in a medical exam room, talks on a landline phone.
Screening tests like mammography and low-dose CT scans can catch cancers early only when people with abnormal results return for the necessary follow-up testing. But many people with abnormal results don’t get this… Learn more
POSTED: 12/22/2023
AUTHOR: Linda Wang
ULACNet investigators at the annual meeting at the  University of Puerto Rico Comprehensive Cancer Center
In this issue we present: the 2023 ULACNet and CAMPO Meetings in San Juan, PR, the long and winding journey in ROCCHHA, the ULACNet-302 site visit, and the New and Improved UNITED webpage.
POSTED: 12/18/2023
A graphic displaying alternative paths from point A to point B: direct, circuitous, and roundabout.
There are many approved medications for reducing breast cancer risk, but they can cause toxic side effects that lead people to forego preventive interventions. Two recent NCI-supported studies looked at ways to provide… Learn more
POSTED: 12/15/2023
Inaugural Cohort of DCP Early Career Scientists
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) is pleased to announce the inaugural cohort of the DCP Early Career Scientist Spotlight Research Seminar Series. The new series of public seminars will… Learn more
POSTED: 12/1/2023
Worta McCaskill-Stevens, M.D.
Worta McCaskill-Stevens, M.D., a medical oncologist, former director of the NCI Community Oncology Research Program (NCORP), and a tireless champion of addressing cancer disparities, passed away peacefully on November 15,… Learn more
POSTED: 11/17/2023
Lori Minasian, M.D., F.A.C.P.
It is not known whether, and to what extent, the benefits of screening with MCD assays will outweigh the harms for the population in which these assays would be used. To address these evidence gaps, NCI, part of the National… Learn more
POSTED: 11/1/2023
AUTHOR: Lori M. Minasian, MD, FACP; Paul F. Pinsky, PhD; Christos Patriotis, PhD, MSc; Elyse LeeVan, MD, MPH; Philip C. Prorok, PhD; and Wendy S. Rubinstein, MD, PhD, FACP, FACMG
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Nationwide Effort Begins to Find Permanent Leader
Brandy Heckman-Stoddard, Ph.D., M.P.H., Chief of the National Cancer Institute (NCI) Division of Cancer Prevention (DCP) Breast and Gynecologic Cancer Research Group (… Learn more
POSTED: 11/1/2023
A daughter sits next to her mother, who's in a wheelchair
Getting a diagnosis and undergoing treatment for a serious illness like cancer rank as some of life’s most stressful experiences. Over the last decade, it’s been increasingly recognized that distress can have an impact on a… Learn more
POSTED: 10/27/2023
AUTHOR: Sharon Reynolds
A collection of healthy foods on the left side of the image (e.g. fruits and vegetables) with unhealthy foods on the right side (e.g., donuts, chips, marshmallows)
A healthier diet has been associated with reduced risk of cancer, but the mechanisms of how that actually works continue to be investigated. In two recent studies, researchers are looking to understand the process on a… Learn more
POSTED: 10/25/2023
Cancer-screening tests that can detect multiple cancer types, or multi-cancer early detection (MCED) tests, have emerged recently as a potential new tool in decreasing cancer morbidity and mortality. Most MCED assays are… Learn more
POSTED: 10/4/2023
An image of a prescription bottle encircled with a reusable symbol.
Two recent publications focus on widely used treatments for other diseases to evaluate possible roles in the prevention of cancer. One looked at the potential of statins, a common heart disease drug, to prevent gynecologic… Learn more
POSTED: 9/11/2023
On May 1-2, 2023, approximately 70 experts from academia, government, industry, and professional organizations globally met with the goal of developing a contemporary working definition or framework for the term ‘precancer… Learn more
POSTED: 9/5/2023
New Funding Opportunity: NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research
National Cancer Institute (NCI) Director Monica Bertagnolli, M.D., today announced the creation of the NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12). This training… Learn more
POSTED: 8/24/2023
David S. Alberts, M.D.
David S. Alberts, M.D., a former director of the University of Arizona Cancer Center, died in late July. As a scientist who was an early and unending advocate for cancer prevention medicine, he will always have the deep gratitude of the National Cancer Institute Division of Cancer Prevention (DCP… Learn more
POSTED: 8/21/2023
Division of Cancer Prevention National Cancer Institute National Institutes of Health Department of Health and Human Services The NCI is seeking an innovative and energetic leader to serve as its Chief, Chemopreventive Agent Development Research Group (CADRG) for the Division of Cancer Prevention… Learn more
POSTED: 8/21/2023
Two outstretched arms holding a heart shaped object in hand.
Cardio-oncology research looks at cancer treatment-related cardiotoxicity, or damage to the heart and cardiovascular system (including heart valves and vessels) that can occur during or after cancer treatment. Over the last… Learn more
POSTED: 8/8/2023